HB1619

House Bill 1619 establishes specific administrative fee requirements for the Arkansas Medicaid Program regarding the delivery of immunizations and monoclonal antibodies used to protect infants and toddlers against respiratory syncytial virus (RSV). The bill mandates that the Medicaid reimbursement fee for these services be set at 100% of the maximum fee established by the state's Vaccines for Children Program. This requirement applies regardless of the specific Medicaid enrollment category of the patient. Additionally, the bill provides civil immunity to individuals and entities involved in prescribing, dispensing, or administering these RSV treatments to eligible patients. This immunity does not apply in cases of gross negligence, recklessness, willful misconduct, or actions not taken in good faith and with reasonable care. The Arkansas Department of Human Services is tasked with seeking any necessary federal waivers or state plan amendments to implement these changes.